ADAMTS17 and Weill-Marchesani syndrome: ADAMTS17 mutations causing WMS seem to decrease the secretion of ADAMTS17 (Evans et al., 2020; Karoulias et al., 2020) or impact the catalytic domain of the protein (Balic et al., 2021), which suggests loss of function mutations leading to an inactive protein.